Failures to Replicate: What Recent Negative Phase 3 Trials Have Taught Us about Amyotrophic Lateral Sclerosis Clinical Research

Failures to Replicate: What Recent Negative Phase 3 Trials Have Taught Us about ALS Research. So many promising Phase 2 trials end in failure. Another reason why we need firms like #NetraMark $AIAI to find sub populations that drugs works on. https:…

Failures to Replicate: What Recent Negative Phase 3 Trials Have Taught Us about Amyotrophic Lateral Sclerosis Clinical Research https://t.co/cCl6kOrtQi